Abiopharma

New Form SCHEDULE 13D - Health Catalyst, Inc. Filed: 2026-01-21 AccNo: 0001193125-26-017290 Size: 457 KB

Ekso Bionics Prices $5.852 million Private Placement

NeuroSense Granted U.S. Patent for Treatment of Alzheimers Disease

NeuroSense Granted U.S. Patent for Treatment of Alzheimers Disease

New Form SCHEDULE 13G - NEUROCRINE BIOSCIENCES INC Filed: 2026-01-21 AccNo: 0000019617-26-000046 Size: 6 KB

BRAINSWAY (BWAY) Files Form 6-K

Hoth Therapeutics Notification (HOTH)

Legend Biotech (LEGN) Files Form 6-K

New Form SCHEDULE 13G - FOXO TECHNOLOGIES INC. Filed: 2026-01-21 AccNo: 0001535610-26-000014 Size: 9 KB

New Form SCHEDULE 13G/A - BAXTER INTERNATIONAL INC Filed: 2026-01-21 AccNo: 0001027796-26-000005 Size: 7 KB

New Form SC TO-T/A - Applied Therapeutics, Inc. Filed: 2026-01-21 AccNo: 0001193125-26-017254 Size: 42 KB

Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Healths Most Evidence-Based Platforms

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247

DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE